Polskie Archiwum Medycyny Wewnetrznej
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Factor XI inhibition in cardiovascular disease.
134:16799.
2024
-
Healthy vaccinee effect: a bias not to be forgotten in observational studies on COVID-19 vaccine effectiveness. Authors's reply.
134:16691.
2024
-
The concept of medical futility is not similar to the concept of persistent therapy. Authors' reply.
134:16667.
2024
-
Mortality and major postoperative complications within one year after vascular surgery: a prospective cohort study.
134:16645.
2024
-
Authors’ reply to the letters concerning the article “Effectiveness of the BNT162b2 vaccine in preventing COVID-19–associated deaths in Poland”.
133:16575.
2023
-
Avoiding medical futility in patients dying in the hospital: a position statement of the Polish Society of Internal Medicine’s Working Group on Medical Futility at Internal Medicine Units.
133:16567.
2023
-
When malaria imitates thrombotic thrombocytopenic purpura: the importance of patients’ history and physicians' awareness of uncommon diseases.
133:16569.
2023
-
<i>Polish Archives of Internal Medicine</i>: a journal connecting generations.
133:16480.
2023
-
The 3 Wishes Project: toward spiritual care at the end of life.
133:16465.
2023
-
The temporal changes of hemostatic activity in hospitalized patients with COVID-19: a prospective observational study.
133:16446.
2023
-
Surviving Sepsis Campaign Guidelines 2021: highlights for the practicing clinician.
132:16290.
2022
-
Will molnupiravir be a game changer in our efforts to safe COVID-19 outpatients?.
132:16183.
2022
-
Should we use the transradial approach in cardiogenic shock?.
131:409-410.
2021
-
Quality and methodology of clinical practice guidelines on antiviral pharmacotherapy for COVID-19 during the early phase of the pandemic.
131:356-360.
2021
-
Corrections: Discontinuation of hydration and nutrition in vegetative or minimally conscious state: position statement of the Polish Association for Spiritual Care in Medicine 2020.
131:221-221.
2021
-
Discontinuation of hydration and nutrition in vegetative or minimally conscious state: no straightforward answer. Authors’ reply.
131:211-212.
2021
-
Discontinuation of hydration and nutrition in vegetative or minimally conscious state: position statement of the Polish Association for Spiritual Care in Medicine 2020.
131:111-113.
2021
-
Evidence does not make decisions, people do.
130:816-817.
2020
-
Evidence-based medicine and COVID-19: human important outcome measures. Making decisions under conditions of uncertainty.
130:714-715.
2020
-
Investigations and management of chronic cough: update from the European Respiratory Society Chronic Cough Taskforce 2020.
130:789-795.
2020
-
Admission to surgery time in Polish patients with hip fractures: temporal trends in the last decade and association with duration of hospitalization and in-hospital mortality.
130:506-511.
2020
-
Acute respiratory distress syndrome and steroids in the shadow of coronavirus disease 2019.
130:266-267.
2020
-
Attitudes of health care professionals towards the introduction of rapid response teams in Poland – a survey study after six months of a pilot program in 25 hospitals.
129:949-955.
2019
-
General health checks are not beneficial for general adult population.
129:839-841.
2019
-
Management of asthma exacerbation in adults – guidelines for primary care doctors.
129:842-849.
2019
-
Perioperative management of patients who are receiving antiplatelet therapy: a case-based, evidence-informed approach.
128:771-778.
2018
-
De-prescribing benzodiazepine receptor agonists taken for insomnia: a review and key messages from practice guidelines.
129:43-49.
2018
-
Advances in the treatment of mild asthma: recent evidence.
128:545-549.
2018
-
Knee osteoarthritis - when arthroscopy can help.
128:121-125.
2018
-
Leukotrienes biosynthesis in coronary artery disease - results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) study.
128:43-51.
2017
-
Primary hyperparathyroidism: diagnosis and management in 2017.
127:438-441.
2017
-
Challenges of managing asthma in an elderly population.
127:291-293.
2017
-
Treatment of hypertension: When to start? What is the target? Dr. Franz H. Messerli in an interview with Dr. Roman Jaeschke: part 2.
127:221-222.
2017
-
Treatment of hypertension: choosing the first‑line treatment. Dr. Franz H. Messerli in an interview with Dr. Roman Jaeschke: part 1.
127:219-220.
2017
-
Microbiome: fecal transplant in Clostridium difficile and ulcerative colitis. Dr. Paul Moayyedi in an interview with Dr. Roman Jaeschke: part 2.
127:137-138.
2017
-
Microbiome: the beginning of understanding Dr. Paul Moayyedi in an interview with Dr. Roman Jaeschke: part 1.
127:135-136.
2017
-
Cystic fibrosis: past, present, future. Dr. Andreas Freitag in an interview with Dr. Roman Jaeschke.
127:73-75.
2017
-
Managing challenging patients with venous thromboembolism: a practical, case-based approach.
127:41-46.
2017
-
Microbiome: fecal transplant in Clostridium difficile and ulcerative colitis.
127:137-138.
2017
-
Microbiome: the beginning of understanding.
127:135-136.
2017
-
2015 in hematology and thromboembolism. Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 1.
126:1024-1024.
2016
-
HOPE‑3, BP treatment, milestones in CV prevention. Dr. Salim Yusuf in an interview with Dr. Akbar Panju and Dr. Roman Jaeschke.
126:1033-1035.
2016
-
Is retraction sufficient for medical papers?.
126:1017-1018.
2016
-
Milestones in VTE treatment. Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 2.
126:1025-1025.
2016
-
Treatment of asthma: predicting the future of atopic disease treatment Dr. Paul O’Byrne in an interview with Dr. Roman Jaeschke: part 2.
126:1031-1032.
2016
-
Treatment of asthma: roles of different classes of drugs Dr. Paul O’Byrne in an interview with Dr. Roman Jaeschke: part 1.
126:1028-1030.
2016
-
VTE treatment in 201 6 and future challenges Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 3.
126:1026-1027.
2016
-
Aspirin in prevention of cardiovascular events. Dr. Gordon Guyatt in an interview with Dr. Roman Jaeschke.
126:909-909.
2016
-
Drugs in diabetes in 2016, changes in endocrinology in 2015. Dr. Hertzel Gerstein in an interview with Dr. Roman Jaeschke.
126:907-908.
2016
-
Safety of long‑acting β2‑agonists: a little bit of history. Dr. Paul O’Byrne in an interview with Dr. Roman Jaeschke: part 1.
126:910-911.
2016
-
Safety of long‑acting ß2‑agonists: current state of knowledge. Dr. Paul O’Byrne in an interview with Dr. Roman Jaeschke: part 2.
126:912-913.
2016
-
BRIDGE trial. Dr. James Douketis in an interview with Dr. Roman Jaeschke: part 1.
126:798-800.
2016
-
Do not consider amiodarone, give it! Comment on antiarrhythmic drugs for shock‑refractory ventricular fibrillation or pulseless ventricular tachycardia.
126:791-792.
2016
-
Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes mellitus. Dr. Hertzel Gerstein in an interview with Dr. Roman Jaeschke.
126:803-805.
2016
-
Periprocedural risk of bleeding and thrombosis: to bridge or not to bridge. Dr. James Douketis in an interview with Dr. Roman Jaeschke: part 2.
126:801-802.
2016
-
Resuscitation in sepsis in 2016. What’s new? Dr. Waleed Alhazzani in an interview with Dr. Roman Jaeschke: part 1.
126:794-795.
2016
-
SPRINT trial and blood pressure treatment. Dr. Gordon Guyatt in an interview with Dr. Roman Jaeschke.
126:806-807.
2016
-
Stress ulcer prophylaxis in critical care: a 2016 perspective Dr. Waleed Alhazzani in an interview with Dr. Roman Jaeschke: part 2.
126:796-797.
2016
-
Optimizing the safety of treatment for venous thromboembolism in the era of the direct oral anticoagulants.
126:688-696.
2016
-
Targeting blood pressure in people with diabetes mellitus.
126:411-418.
2016
-
How to treat ankylosing spondylitis and nonradiographic axial spondyloarthritis. Key practical messages from the 2015 American College of Rheumatology recommendations.
126:254-261.
2016
-
2015 in hematology and thromboembolism.
126:1024-1024.
2016
-
Milestones in VTE treatment.
126:1025-1025.
2016
-
Cochrane Collaboration w Polsce.
125:5-15.
2015
-
Od danych naukowych do praktycznych zaleceń – tworzenie wytycznych według metodologii GRADE.
125:26-41.
2015
-
Proces przygotowywania przeglądów systematycznych, z uwzględnieniem przeglądów Cochrane.
125:16-25.
2015
-
Cochrane Collaboration in Poland.
125:5-15.
2015
-
From evidence to recommendations: developing health care guidelines following the GRADE approach.
125:26-41.
2015
-
Process of developing systematic reviews, including Cochrane reviews.
125:16-25.
2015
-
Flexible bronchoscopy under conscious sedation with midazolam and fentanyl can be safely performed by nonanesthesiologists.
125:869-871.
2015
-
Perioperative anticoagulant management in patients with atrial fibrillation: practical implications of recent clinical trials.
125:666-671.
2015
-
Rapidly progressive interstitial lung fibrosis in a patient with amyopathic dermatomyositis and anti‑MDA5 antibodies.
125:685-686.
2015
-
Corticosteroids in the treatment of community-acquired pneumonia: an evidence summary.
125:570-575.
2015
-
Stroke prevention in asymptomatic carotid artery disease: revascularization of carotid stenosis is not the solution.
125:363-369.
2015
-
Comment on “Our prescription drugs kill us in large numbers”.
125:105-106.
2015
-
New data on noninvasive ventilation in stable chronic obstructive pulmonary disease: revolutionary or evolutionary?.
125:5-7.
2015
-
Intraaortic balloon pump in patients with cardiogenic shock complicating myocardial infarction. A systematic review and meta-analysis of randomized trials.
125:181-190.
2015
-
What is a network meta-analysis and how can we use it to inform clinical practice?.
124:659-660.
2014
-
Should we use β‑blockers for myocardial infarction?.
124:569-572.
2014
-
Strawberry gingivitis as the first manifestation of granulomatosis with polyangiitis.
124:551-552.
2014
-
Rare disease registries: an initiative to establish vasculitis registry in Poland.
124:143-144.
2014
-
Practical aspects of new oral anticoagulant use in atrial fibrillation.
124:124-135.
2014
-
Pregnancy-related H1N1 influenza and severe acute respiratory distress syndrome successfully treated with extracorporeal membrane oxygenation despite difficult vascular access.
124:136-137.
2014
-
Fluid resuscitation in severe sepsis and septic shock: systematic description of fluids used in randomized trials (vol 123, pg 603, 2013).
124:77-77.
2014
-
Fluid resuscitation in severe sepsis and septic shock: systematic description of fluids used in randomized trials.
123:603-608.
2013
-
Is there a role for the novel oral anticoagulants in patients with an acute coronary syndrome? A review of the clinical trials.
123:617-622.
2013
-
Cardiac involvement in hypereosinophilic syndrome.
123:253-254.
2013
-
β‑blockers in heart failure – are all created equal?.
123:204-205.
2013
-
Emerging concepts and therapies for chronic obstructive pulmonary disease.
123:303-308.
2013
-
Can daily multivitamin prevent cancer? Results from the Physicians’ Health Study.
123:83-84.
2013
-
When are biomarkers useful in the management of airway diseases?.
123:183-188.
2013
-
New treatment approaches for asthma.
123:11-13.
2013
-
Menopausal hormone therapy for the primary prevention of chronic conditions. U.S. Preventive Services Task Force Recommendation Statement.
123:112-117.
2013
-
Menopausal hormone therapy for the primary prevention of chronic conditions.
123:112-117.
2013
-
Safety of a perioperative strategy for the management of obstructive sleep apnea in bariatric surgery patients: a single Bariatric Center of Excellence experience.
122:641-643.
2012
-
Time for reflection on patient’s safety in healthcare.
122:512-513.
2012
-
Troponin T level and mortality risk after noncardiac surgery: practical implications of the VISION study.
122:499-503.
2012
-
Management of patients who are receiving warfarin or a new oral anticoagulant and require urgent or emergency surgery.
122:437-442.
2012
-
Stress ulcer prophylaxis in critically ill patients: review of the evidence.
122:107-114.
2012
-
Farewell to the Great Internist. Professor Andrzej Szczeklik (1938–2012).
122:5-5.
2012
-
Polish guidelines for the prevention and treatment of venous thromboembolism 2012 update.
122:3-74.
2012
-
Prophylaxis against venous thromboembolism in hospitalized medical patients: an evidence‑based and practical approach.
118:209-215.
2012
-
Specialty outpatient care of diabetic patients in Poland--are we far from treatment targets? Rationale, design, and preliminary results of the OPTIMO study..
121:375-378.
2011
-
Dabigatran as anticoagulant therapy for atrial fibrillation. Which patients should receive it, which patients may not need it, and other practical aspects of patient management.
121:73-80.
2011
-
Specialty outpatient care of diabetic patients in Poland – are we far from treatment targets? Rationale, design, and preliminary results of the OPTIMO study.
121:375-378.
2011
-
Graduated compression stockings to prevent venous thromboembolism in hospital. Evidence from patients with acute stroke.
121:40-43.
2011
-
Is newly diagnosed type 2 diabetes treated according to the guidelines? Results of the Polish ARETAEUS1 study..
121:7-17.
2011
-
Global guidelines for asthma management. Summary of the current status and future challenges.
120:511-517.
2010
-
New once-daily, long-acting inhaled β2-agonist: what role will it play in the treatment of chronic obstructive pulmonary disease?.
120:381-382.
2010
-
A single dose of aprotinin prevents platelet hyporeactivity after coronary artery bypass graft surgery.
120:321-327.
2010
-
Antiplatelet therapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. Key messages for clinical practice.
120:143-147.
2010
-
Dabigatran: ready for prime time?.
120:137-142.
2010
-
Functional promoter polymorphism of cyclooxygenase‑2 modulates the inflammatory response in stable coronary heart disease.
120:82-88.
2010
-
Polish guidelines for the prevention and treatment of venous thromboembolism 2009 update.
119:3-69.
2009
-
Clinical equivalence testing of inhaled bronchodilators.
119:731-735.
2009
-
Steroid use in critically ill septic patients: acknowledging the uncertainty.
119:694-696.
2009
-
The use of inhaled anticholinergics in chronic obstructive pulmonary disease. Is there cause for concern of cardiovascular safety?.
119:697-698.
2009
-
2009 evidence-based clinical practice guidelines for diagnosing a first episode of lower extremities deep vein thrombosis in ambulatory outpatients.
119:541-549.
2009
-
Characteristics of patients with type 2 diabetes of short duration in Poland: rationale, design and preliminary results of the ARETAEUS1 study.
119:533-540.
2009
-
Is it safe to use a proton pump inhibitor with clopidogrel?.
119:564-568.
2009
-
The efficacy and safety of glucose control algorithms in intensive care: a pilot study of the Survival Using Glucose Algorithm Regulation (SUGAR) trial.
119:439-446.
2009
-
Should we step‑up or step‑down in the treatment of new‑onset dyspepsia in primary care?.
119:391-396.
2009
-
Angiotensin-receptor blockers in prevention of cardiovascular events: are they as effective as angiotensin-converting enzyme inhibitors?.
119:8-10.
2009
-
International Diabetes Federation document concerning postmeal glycemic control: assessment of quality of clinical practice guidelines using AGREE instrument.
119:18-25.
2009
-
New oral anticoagulants: not quite there yet.
119:53-59.
2009
-
The use of inhaled anticholinergics in chronic obstructive pulmonary disease: is there cause for concern? A review of evidence from clinical trials.
119:74-79.
2009
-
[Polish guidelines for the prevention and treatment of venous thromboembolism: 2009 update]..
119 Suppl 1:1-69.
2009
-
Is it safe to use long‑acting β‑agonists in asthma and chronic obstructive pulmonary disease? Implications of recent trials and meta‑analyses.
118:761-766.
2008
-
Effects of megestrol acetate in patients with cancer anorexia‑cachexia syndrome – a systematic review and meta‑analysis.
118:636-644.
2008
-
Should physicians initiate β‑blocker therapy in patients undergoing non‑cardiac surgery? Insights from the POISE trial.
118:616-618.
2008
-
The safety of formoterol among patients with asthma using inhaled corticosteroids. Systematic review and meta‑analysis.
118:627-635.
2008
-
Hand hygiene in the intensive care unit: prospective observations of clinical practice.
118:543-547.
2008
-
Does early intervention with inhaled corticosteroids alter the natural history of mild persistent asthma?.
118:441-444.
2008
-
2007 update of the Global Initiative for Asthma management and prevention: what’s new?.
118:179-180.
2008
-
2008 update of international guidelines for the management of severe sepsis and septic shock: should we change our current clinical practice?.
118:92-95.
2008
-
Perioperative management of antithrombotic therapy.
118:201-208.
2008
-
Anticoagulation in patients with cancer: an overview of reviews.
118:183-183.
2008
-
Anticoagulation for the prevention of central venous catheter associated-thrombosis: an evidence based commentary.
117:494-496.
2007
-
Are heparins anti-neoplastic agents?.
117:491-493.
2007
-
Calcium and vitamin D for osteoporotic fracture prevention.
117:441-442.
2007
-
Can clinical practice guidelines lead astray?.
117:132-135.
2007
-
Patient reported outcomes: general principles of development and interpretability.
117:125-131.
2007
-
Fondaparinux – evolution or revolution in anticoagulant care?.
117:65-67.
2007
-
Combining LABA and ICS in patients with severe COPD.
117:6-8.
2007
-
[The role of heparinoids in the treatment of vascular diseases]..
99:430-435.
1998
-
[Vasculitis with digital ischemic necrosis preceding diagnosis of malignancy]..
94:364-366.
1995
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)